Biotech

All Articles

Biogen's chief executive officer stated no risky handle 2023. He's ready to become bold

.While Biogen's pharma peers are hunting for late-stage assets with little bit of danger, chief exec...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been a biotech seeking a pipeline after it ditched its own lead prope...

Biogen ignores Denali Alzheimer's collab

.Biogen has restored legal rights to an early Alzheimer's condition program to Denali Therapies, lea...

Takeda water faucets brand-new mind people oncology company-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable management hirings, firings a...

Vertex, beaten through AATD again, loses 2 properties on throw out heap

.Tip's attempt to handle an unusual hereditary illness has actually reached yet another trouble. The...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter profits file had not been except major headlines. The firm welcomed a ...

Galapagos pauses CAR-T cell therapy trial over Parkinsonism instance

.Galapagos has stopped application in a test of a BCMA-directed CAR-T tissue treatment, pushing the ...

James Wilson leaving Penn to launch 2 new biotechs

.After more than 30 years, gene therapy trailblazer James Wilson M.D., Ph.D., is actually leaving th...

3 biotechs try to beat the summer season warm by losing staff

.As biotechs attempt to switch a new web page in August, at the very least three providers have shed...

venBio raises $528M for 5th lifestyle scientific researches VC fund

.Veteran venture capital organization venBio has lifted an additional half a billion bucks to buy bi...